odesivimab
E468965
Odesivimab is a monoclonal antibody used as part of an antibody cocktail therapy for the treatment of Ebola virus infection.
Statements (20)
| Predicate | Object |
|---|---|
| instanceOf |
monoclonal antibody
ⓘ
therapeutic antibody ⓘ |
| actsOnOrganism | Zaire ebolavirus NERFINISHED ⓘ |
| developedAs | component of a monoclonal antibody cocktail ⓘ |
| hasBiologicalRole | antiviral agent ⓘ |
| hasDrugClass | antiviral monoclonal antibody ⓘ |
| hasIndication | Ebola virus infection ⓘ |
| hasMolecularTarget | Ebola virus glycoprotein ⓘ |
| isPartOfRegimen | antibody cocktail for Ebola ⓘ |
| mechanismOfAction | neutralization of Ebola virus via binding to viral glycoprotein ⓘ |
| partOf | antibody cocktail therapy for Ebola virus disease ⓘ |
| routeOfAdministration | intravenous ⓘ |
| targetPathogen |
Ebolavirus
NERFINISHED
ⓘ
Zaire ebolavirus species NERFINISHED ⓘ |
| therapeuticArea |
infectious disease
ⓘ
virology ⓘ |
| treatsDisease | Ebola virus disease NERFINISHED ⓘ |
| usedFor |
treatment of Ebola virus disease
ⓘ
treatment of Zaire ebolavirus infection ⓘ |
| usedIn | combination therapy for Ebola virus disease ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.